SC&H Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $414K | Hold |
1,021
| – | – | 0.07% | 98 |
|
|
2025
Q1 | $508K | Hold |
1,021
| – | – | 0.1% | 87 |
|
|
2024
Q4 | $531K | Sell |
1,021
-171
| -14% | -$89K | 0.11% | 89 |
|
|
2024
Q3 | $737K | Buy |
1,192
+4
| +0.3% | +$2.47K | 0.16% | 79 |
|
|
2024
Q2 | $657K | Hold |
1,188
| – | – | 0.16% | 80 |
|
|
2024
Q1 | $690K | Sell |
1,188
-160
| -12% | -$93K | 0.18% | 77 |
|
|
2023
Q4 | $715K | Sell |
1,348
-132
| -9% | -$70.1K | 0.21% | 69 |
|
|
2023
Q3 | $749K | Hold |
1,480
| – | – | 0.25% | 67 |
|
|
2023
Q2 | $772K | Sell |
1,480
-1
| -0.1% | -$522 | 0.26% | 70 |
|
|
2023
Q1 | $854K | Buy |
1,481
+173
| +13% | +$99.7K | 0.31% | 62 |
|
|
2022
Q4 | $720K | Sell |
1,308
-160
| -11% | -$88.1K | 0.3% | 69 |
|
|
2022
Q3 | $744K | Sell |
1,468
-181
| -11% | -$91.7K | 0.37% | 56 |
|
|
2022
Q2 | $896K | Buy |
1,649
+170
| +11% | +$92.4K | 0.42% | 51 |
|
|
2022
Q1 | $873K | Sell |
1,479
-5
| -0.3% | -$2.95K | 0.42% | 55 |
|
|
2021
Q4 | $990K | Buy |
+1,484
| New | +$990K | 0.55% | 42 |
|